Beta Cell-Targeted PDL1-CTLA4Ig Over-Expression Prevents Autoimmune Diabetes Development and Acute Allogeneic Islets Rejection

被引：0
|
作者：
Ikeda, Yasuhiro [1 ]
El-Khatib, Moustafa [1 ]
Sakuma, Toshie [1 ]
Tonne, Jason [1 ]
Kudva, Yogish [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
MOLECULAR THERAPY | 2014年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
19
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 3 条
  • [1] β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection
    El Khatib, M. M.
    Sakuma, T.
    Tonne, J. M.
    Mohamed, M. S.
    Holditch, S. J.
    Lu, B.
    Kudva, Y. C.
    Ikeda, Y.
    GENE THERAPY, 2015, 22 (05) : 430 - 438
  • [2] β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection
    M M El Khatib
    T Sakuma
    J M Tonne
    M S Mohamed
    S J Holditch
    B Lu
    Y C Kudva
    Y Ikeda
    Gene Therapy, 2015, 22 : 430 - 438
  • [3] The impact of PD-1/PD-L1, CTLA-4, TIM-3 and LAG-3 immune checkpoint receptor expression in the development of acute graft versus host disease (aGVHD) and disease recurrence after allogeneic hematopoietic stem cell transplantation
    Ramzi, Mani
    Dehghani, Mehdi
    Hajimaghsoodi, Maryam
    Golmoghaddam, Hossein
    Arandi, Nargess
    HUMAN IMMUNOLOGY, 2025, 86 (01)
1